Crossmark

Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation

Crossref DOI link: https://doi.org/10.1016/j.aohep.2024.101764

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Suzuki, Takanori

Tamori, Akihiro https://orcid.org/0000-0001-9119-4864
Matsuura, Kentaro

Inoue, Takako

Kusumoto, Shigeru

Hagiwara, Shinya

Sagi, Haruka

Kaneko, Atsushi

Murakami, Shuko

Kawamra, Hayato

Fujiwara, Kei

Aoyagi, Katsumi

Enomoto, Masaru

Kozuka, Ritsuzo

Kataoka, Hiromi

Tanaka, Yasuhito
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (JP23K07359)

Japan Agency for Medical Research and Development (AMED JP24fk0310518)
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2024-11-28
More Information

This article is maintained by: Elsevier

Article Title: Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2024.101764

Content Type: article

Copyright: © 2024 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.